Furthermore, GAL can inhibit the expression of inflammatory mediators such as IL-1β, TNF-α, IL-18, PGE2, and NO in a dose-dependent manner in RA fibroblast-like synovial cells (RAFSCs), as well as the expression of iNOS and COX-2. This evidence concerns the gene TNF and rheumatoid arthritis.